Sex-based clinical and immunological differences in COVID-19.

Bin HuangYun CaiNing LiKening LiZhihua WangLu LiLingxiang WuMengyan ZhuJie LiZiyu WangMin WuWanlin LiWei WuLishen ZhangXinyi XiaShukui WangHongshan ChenQiang-Hu Wang

Published in: BMC infectious diseases (2021)

Males had an unfavorable prognosis, higher inflammation, a lower percentage of lymphocytes, and indolent antibody responses during SARS-CoV-2 infection and recovery. Early medical intervention and close monitoring are important, especially for male COVID-19 patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
randomized controlled trial
oxidative stress
healthcare
peripheral blood
hodgkin lymphoma